The development of longer-acting H<sub>2</sub> receptor antagonists with fewer drug interactions and adverse effects, such as [[ranitidine]] and [[famotidine]], decreased the use of cimetidine, and though it is still used, cimetidine is no longer among the more widely used of the H<sub>2</sub>-receptor antagonists.{{Citation needed|date=August 2016}}

 

